FIELD: biotechnology.
SUBSTANCE: test serum is simultaneously added to the wells of two strips immobilized with a varicella zoster virus antigen, incubated for 50-55 minutes, then one strip is treated once with an aqueous solution of 6 M of urea for 15 minutes, after which both strips are washed and conjugated with specific monoclonal antibodies to human IgG antibodies, incubated for 30 minutes, stained after washing with an aqueous chromogen solution for 10-15 minutes at room temperature, the reaction is stopped with a solution of 0.5 M of sulfuric acid, optical density is determined with a spectrophotometer, the avidity index is calculated using the formula: avidity index (AI) = (optical density of the sample treated with a solution of 6 M of urea/optical density of the sample without treatment with a solution of 6 M of Urea)X100%, and with an AI level less than 45% and up to 50% an acute period is diagnosed, with AI more than 50% and less than 65% - an early past infection, with AI of 65% and more than 70% - the late disease period is diagnosed.
EFFECT: method is effective and informative for diagnostics of the period of infectious disease caused by the varicella zoster virus in children, used to establish acute infection, activation of chronic persistent infection, and high protective immunity, which is decisive for determination of disease etiology and choice of adequate therapeutic tactics.
3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING AVIDITY OF IMMUNOGLOBULIN G TO HERPES VIRUS TYPE 6 | 2015 |
|
RU2596794C1 |
TEST SYSTEM FOR SIMULTANEOUS DETECTION OF HUMORAL MARKERS OF HUMAN HERPES VIRUS INFECTION | 2019 |
|
RU2724897C1 |
METHOD OF OBTAINING LIVE CULTURAL ATTENUATED VACCINE FOR THE PREVENTION OF VARICELLA | 2016 |
|
RU2637093C1 |
DIAGNOSTIC TECHNIQUE FOR ACUTE VIRAL HEPATITIS A IN CHILDREN | 2011 |
|
RU2479847C2 |
VIRAL STRAIN FOR OBTAINING ATTENUATED LIVE CULTURE VACCINE FOR PREVENTION AND TREATMENT OF HERPES ZOSTER FOR ADULT POPULATION | 2020 |
|
RU2750818C1 |
METHOD OF PREDICTING RISK OF NEUROLOGICAL COMPLICATIONS IN CASE OF CHICKEN POX IN CHILDREN | 2012 |
|
RU2481786C1 |
STRAIN "vFIRAVAX" FOR PRODUCING AN ATTENUATED ALIVE CULTURE VACCINE FOR PREVENTING VARICELLA | 2019 |
|
RU2693440C1 |
INACTIVATED VACCINES AGAINST VARICELLA-ZOSTER VIRUS, METHODS FOR THEIR PRODUCTION AND APPLICATION | 2011 |
|
RU2633058C2 |
DIAGNOSTIC TECHNIQUE FOR THE COMBINED INFECTION IN CHILDREN WITH ACUTE RESPIRATORY INFECTIONS | 2019 |
|
RU2706126C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF HERPES VIRUS MIXED INFECTION | 2020 |
|
RU2739854C1 |
Authors
Dates
2017-08-28—Published
2016-04-18—Filed